Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia Slovenia (East Europe) By (Infant & Adult) Forecast

Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia Slovenia (East Europe) By (Infant & Adult) Forecast

Table of Contents

1. Executive Summary

2. Eastern Europe Countries Seasonal Influenza Vaccinated Population
2.1 Seasonal Influenza Vaccinated Child Population in Eastern Europe Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Eastern Europe Countries

3. Eastern Europe Countries Seasonal Influenza Vaccine Market
3.1 Seasonal Influenza Child Vaccine Market in Eastern Europe Countries
3.2 Seasonal Influenza Adult Vaccine Market in Eastern Europe Countries

4. Seasonal Influenza Vaccine Market Share Analysis - Eastern Europe Countries
4.1 Eastern Europe Countries Seasonal Influenza Vaccine Market Share
4.2 Eastern Europe Countries Seasonal Influenza Child Vaccine Market Share
4.3 Eastern Europe Countries Seasonal Influenza Adult Vaccine Market Share

5. Hungary
5.1 Hungary Seasonal Influenza Vaccinated Population Analysis
5.1.1 Hungary Seasonal Influenza Vaccinated Population
5.1.2 Hungary Seasonal Influenza Vaccinated Child Population
5.1.3 Hungary Seasonal Influenza Vaccinated Adult Population
5.2 Hungary Seasonal Influenza Vaccine Market Analysis
5.2.1 Hungary Seasonal Influenza Vaccine Market
5.2.2 Hungary Seasonal Influenza Child Vaccine Market
5.2.3 Hungary Seasonal Influenza Adult Vaccine Market

6. Romania
6.1 Romania Seasonal Influenza Vaccinated Population Analysis
6.1.1 Romania Seasonal Influenza Vaccinated Population
6.1.2 Romania Seasonal Influenza Vaccinated Child Population
6.1.3 Romania Seasonal Influenza Vaccinated Adult Population
6.2 Romania Seasonal Influenza Vaccine Market Analysis
6.2.1 Romania Seasonal Influenza Vaccine Market
6.2.2 Romania Seasonal Influenza Child Vaccine Market
6.2.3 Romania Seasonal Influenza Adult Vaccine Market

7. Slovakia
7.1 Slovakia Seasonal Influenza Vaccinated Population Analysis
7.1.1 Slovakia Seasonal Influenza Vaccinated Population
7.1.2 Slovakia Seasonal Influenza Vaccinated Child Population
7.1.3 Slovakia Seasonal Influenza Vaccinated Adult Population
7.2 Slovakia Seasonal Influenza Vaccine Market Analysis
7.2.1 Slovakia Seasonal Influenza Vaccine Market
7.2.2 Slovakia Seasonal Influenza Child Vaccine Market
7.2.3 Slovakia Seasonal Influenza Adult Vaccine Market

8. Slovenia
8.1 Slovenia Seasonal Influenza Vaccinated Population Analysis
8.1.1 Slovenia Seasonal Influenza Vaccinated Population
8.1.2 Slovenia Seasonal Influenza Vaccinated Child Population
8.1.3 Slovenia Seasonal Influenza Vaccinated Adult Population
8.2 Slovenia Seasonal Influenza Vaccine Market Analysis
8.2.1 Slovenia Seasonal Influenza Vaccine Market
8.2.2 Slovenia Seasonal Influenza Child Vaccine Market
8.2.3 Slovenia Seasonal Influenza Adult Vaccine Market

9. Seasonal Influenza Vaccine - Growth Drivers
9.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
9.2 Declining Child Population & Rising Ageing Population in Eastern Europe Region
9.3 Rising Healthcare Expenditure Share of the Eastern Europe Countries to GDP

10. Seasonal Influenza Vaccine - Challenges
10.1 Regulatory Challenges with New and Novel Influenza Vaccines
10.2 Lack of Healthcare Infrastructure
10.3 Limited Reimbursement and Access to the Vaccines

List of Table

Table 9 1: Baltic Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015

List of Figures

Figure 2 1: East Europe - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 2 2: East Europe - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 2 3: East Europe - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: East Europe - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: East Europe - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: East Europe - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: East Europe - Seasonal Influenza Vaccine Market (Thousand), 2011 - 2016
Figure 3 2: East Europe - Forecast for Seasonal Influenza Vaccine Market (Thousand), 2017 - 2022
Figure 3 3: East Europe - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 4: East Europe - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 5: East Europe - Seasonal Influenza Adult Vaccine Market (Thousand), 2011 - 2016
Figure 3 6: East Europe - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand), 2017 - 2022
Figure 4 1: East Europe - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: East Europe - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: East Europe - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: East Europe - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: East Europe - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: East Europe - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Hungary - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 5 2: Hungary - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 5 3: Hungary - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Hungary - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Hungary - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Hungary- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Hungary - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Hungary - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Hungary - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Hungary - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Hungary - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Hungary - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Romania - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 6 2: Romania - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 6 3: Romania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Romania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Romania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Romania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Romania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Romania - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Romania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Romania - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 11: Romania - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 12: Romania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Slovakia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 7 2: Slovakia - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 7 3: Slovakia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Slovakia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Slovakia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Slovakia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Slovakia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 8: Slovakia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 9: Slovakia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 10: Slovakia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 11: Slovakia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 12: Slovakia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 1: Slovenia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 8 2: Slovenia - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 8 3: Slovenia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Slovenia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Slovenia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Slovenia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Slovenia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 8: Slovenia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 9: Slovenia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 10: Slovenia - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 11: Slovenia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 12: Slovenia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
Figure 9 2: Eastern Countries - Child Population (Thousand), 2010 - 2016
Figure 9 3: Eastern Countries - Forecast for Child Population (Thousand), 2017 - 2022
Figure 9 4: Eastern Countries - Ageing Population (Thousand), 2010 - 2016
Figure 9 5: Eastern Countries - Forecast for Ageing Population (Thousand), 2017 - 2022
Figure 10 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs